世界中医药

目的：观察全息汤治疗慢性主观性头晕（Chronic Subjective Dizziness，CSD）的临床疗效。方法：将90例CSD患者随机分为治疗组（口服全息汤加减）和对照组（口服盐酸氟西汀胶囊）各45例，治疗4周为1个疗程。治疗前后采用眩晕残障程度量表（Dizziness Handicap Inventory，DHI）评估疗效。结果：2组治疗后DHI分项评分及总评分均较治疗前有显著改善(P<0.05)。治疗组治疗后DHI功能、生理评分及总评分均优于对照组，差异有统计学意义(P<0.05)，而情感评分与对照组无统计学意义（P>0.05）。对照组不良反应发生率为33.3%，而治疗组严格依照兼见症加减，未出现不良反应。结论：全息汤加减能够明显改善CSD患者以头晕为主诉的临床征候群，较好的帮助患者恢复了发病前的工作生活能力以及业余爱好，与常规西药治疗相比疗效安全可靠。

English Summary:

To observe the therapeutic effect of modified Quanxi decoction therapy in treating chronic subjective dizziness (CSD).Methods:Ninety cases of CSD were randomly divided into observation group(45 cases) and control group(45 cases). In the observation group, each case was treated with modified Quanxi decoction, while cases in the control group were treated with Fluoxetine Hydrochloride capsules. The differences of effect were observed by the scores of the Dizziness Handicap Inventory(DHI) before and after the treatment for 4 weeks.Results:The division scores and total score of DHI in both two groups were improved than before the treatment(P<0.05). After treatment, functional scores, physiology scores, and total scores of DHI of the observation group were better than those of the control group(P<0.05). However, there were not significant differences between the two groups on the emotional scores of DHI after the treatment. The incidence of adverse reactions was 33.3% in control group, while through strict modification of the medicine in accordance with accompanied symptom, no adverse reaction were seen in the observation group.Conclusion:Quanxi decoction can significantly improve the CSD patients′ s clinical symptoms of which the chief complaint was dizziness and help the CSD patients to restore working and living abilities. Compared with the conventional treatment of western medicine, Quanxi deconction is safer and more reliable in the treatment of CSD.

查看全文查看/发表评论下载PDF阅读器